Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Inflammatory Bowel Diseases

Free Subscription Articles published in Dig Dis Sci Retrieve available abstracts of 252 articles: HTML format

Single Articles

September 2025
1. JAMAL F, Odeh NB, Alatout MHI, Khan MA, et al
   Diet in Ulcerative Colitis: A Narrative Review of Its Role in Pathogenesis and Treatment.
   Dig Dis Sci. 2025 Sep 22. doi: 10.1007/s10620-025-09387.
   PubMed     Abstract available
   
   
   
2. BRONZE S, Shenoy S, Agrawal M, Polydorides AD, et al
   Prevalence and Clinical Features of Incidental Inflammatory Bowel Disease Identified During Screening and Surveillance Colonoscopy.
   Dig Dis Sci. 2025 Sep 19. doi: 10.1007/s10620-025-09400.
   PubMed     Abstract available
   
   
   
3. GORE E, Femino C, Aronskyy I, Miller A, et al
   The Patient Experience with Point-of-Care Intestinal Ultrasound for Inflammatory Bowel Disease Monitoring: A Multicenter Study.
   Dig Dis Sci. 2025 Sep 18. doi: 10.1007/s10620-025-09390.
   PubMed     Abstract available
   
   
   
4. SACHAR M, Rojanasopondist P, Beaty W, Fernandez C, et al
   Safety and Efficacy of Ustekinumab and Vedolizumab Among Older Adults with Inflammatory Bowel Disease.
   Dig Dis Sci. 2025 Sep 16. doi: 10.1007/s10620-025-09395.
   PubMed     Abstract available
   
   
   
5. NGUYEN B, Quon S
   Is Inflammatory Bowel Disease a Risk Factor for Perforation During Diagnostic Colonoscopy? A Systematic Review and Meta-Analysis.
   Dig Dis Sci. 2025 Sep 13. doi: 10.1007/s10620-025-09392.
   PubMed     Abstract available
   
   
   
6. KUCHA P, Rawa T, Kiljan J, Zagorowicz E, et al
   Severe Primary Epstein-Barr Virus Infection in a Young Female with Crohn's Disease Treated with Upadacitinib.
   Dig Dis Sci. 2025 Sep 13. doi: 10.1007/s10620-025-09391.
   PubMed    
   
   
   
7. LUO M, Ye L, Ju J, Li Z, et al
   Rectal Metastasis Mimicking Inflammatory Bowel Disease.
   Dig Dis Sci. 2025 Sep 13. doi: 10.1007/s10620-025-09381.
   PubMed    
   
   
   
8. YANG X, Xie F
   Clinical Insights on "Tolerability and Effectiveness of Glucagon?Like Peptide?1 Receptor Agonists in Patients with Inflammatory Bowel Disease".
   Dig Dis Sci. 2025 Sep 6. doi: 10.1007/s10620-025-09349.
   PubMed    
   
   
   
9. ISHIDA N, Sugimoto K
   Annual Infliximab Monitoring After Treatment Optimization.
   Dig Dis Sci. 2025;70:2944-2946.
   PubMed     Abstract available
   
   
   
10. WANG C, Lv G, Chen E, Xue Y, et al
    Cross-Trait Cross-Genome Cross-Organ Analysis of Gastrointestinal Disorders and Depression.
    Dig Dis Sci. 2025;70:3021-3033.
    PubMed     Abstract available
    
    
    August 2025
11. DAI F, Ye S, Zhu Y, Zhang J, et al
    Identification of Inflammation-Related Diagnostic Biomarker and Molecular Subtypes in Ulcerative Colitis Based on Machine Learning.
    Dig Dis Sci. 2025 Aug 26. doi: 10.1007/s10620-025-09312.
    PubMed     Abstract available
    
    
    
12. WENG J, Alizadeh M, Friedman S
    Glucagon-Like Peptide-1 Receptor Agonist Therapy Does Not Increase Gastrointestinal Adverse Events in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2025 Aug 19. doi: 10.1007/s10620-025-09344.
    PubMed     Abstract available
    
    
    
13. MENCHEN L
    Gaining the Upper Hand - Upadacitinib for Crohn's Disease with Ileostomy: A Real-World Gap Addressed.
    Dig Dis Sci. 2025 Aug 14. doi: 10.1007/s10620-025-09313.
    PubMed    
    
    
    
14. STAMMERS M, Sartain S, Cummings JRF, Kipps C, et al
    Identification of Cohorts with Inflammatory Bowel Disease Amidst Fragmented Clinical Databases via Machine Learning.
    Dig Dis Sci. 2025 Aug 13. doi: 10.1007/s10620-025-09323.
    PubMed     Abstract available
    
    
    
15. REHMAT M, Ul Haq U, Saddique MN, Mehmood L, et al
    Efficacy of Whole-Food Based Anti-inflammatory Dietary Interventions in the Management of Ulcerative Colitis: A Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2025 Aug 12. doi: 10.1007/s10620-025-09332.
    PubMed     Abstract available
    
    
    
16. ANDERS-RUMSEY J, Kasmikha L, Chiang M, Hodish G, et al
    Inflammatory Bowel Disease Self-Care Behaviors in Context of Psychosocial Factors.
    Dig Dis Sci. 2025 Aug 12. doi: 10.1007/s10620-025-09326.
    PubMed     Abstract available
    
    
    
17. BUTNARIU M
    Exercising Options: Personalized Exercise Program Improves Fatigue and Quality of Life Scores in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2025 Aug 9. doi: 10.1007/s10620-025-09315.
    PubMed    
    
    
    
18. CHAMAN LAL K, Zia Z, Naveed M, Khan M, et al
    Comment on "Clinical, Radiological and Pharmacokinetic Data of CT?P13 Subcutaneous in Individuals with Fistulizing Anoperineal Crohn's Disease".
    Dig Dis Sci. 2025 Aug 5. doi: 10.1007/s10620-025-09311.
    PubMed    
    
    
    July 2025
19. FATHALLAH N, Draullette M, Kirchgesner J, Paul S, et al
    Clinical, Radiological and Pharmacokinetic Data of CT-P13 Subcutaneous in Individuals with Fistulizing Anoperineal Crohn's Disease.
    Dig Dis Sci. 2025 Jul 25. doi: 10.1007/s10620-025-09210.
    PubMed     Abstract available
    
    
    
20. DEVI J, Jena A, Hassan A, Lohia R, et al
    Global Training in Inflammatory Bowel Disease: Addressing Growing Challenges in IBD.
    Dig Dis Sci. 2025 Jul 24. doi: 10.1007/s10620-025-09263.
    PubMed     Abstract available
    
    
    
21. VALLE NP, Hamidi S, Rodriguez F, Limketkai BN, et al
    Correction: Cerebral Crohn's Disease-Not Your Typical Brain-Gut Connection.
    Dig Dis Sci. 2025 Jul 18. doi: 10.1007/s10620-025-09253.
    PubMed    
    
    
    
22. ALIZADEH M, Cross RK, Cohen E
    Nervous Breakdown: Chronic Inflammatory Demyelinating Polyneuropathy as an Extra-Intestinal Manifestation of Ulcerative Colitis.
    Dig Dis Sci. 2025 Jul 12. doi: 10.1007/s10620-025-09184.
    PubMed    
    
    
    
23. WANG G, Ching C, Hanna Y, Tandon P, et al
    Health Maintenance and Unique Health Needs of the Perimenopausal and Postmenopausal Woman with Inflammatory Bowel Disease.
    Dig Dis Sci. 2025 Jul 8. doi: 10.1007/s10620-025-09199.
    PubMed     Abstract available
    
    
    
24. SMYTH MJ, Dolinger MT, Kellar A, Spencer EA, et al
    Sonographic Transmural Induction Outcomes Across Advanced Therapies in Crohn's Disease.
    Dig Dis Sci. 2025 Jul 6. doi: 10.1007/s10620-025-09181.
    PubMed     Abstract available
    
    
    
25. ZHU D, Chen X
    Identification and Confirmation of Shared Etiology and Hub Biomarkers in Nonalcoholic Steatohepatitis and Crohn's Disease.
    Dig Dis Sci. 2025 Jul 1. doi: 10.1007/s10620-025-09190.
    PubMed     Abstract available
    
    
    
26. FORBES AJ, Frampton CMA, Day AS, Gearry RB, et al
    20-Year Mortality in a Population-Based Cohort of Patients with Inflammatory Bowel Disease from New Zealand.
    Dig Dis Sci. 2025 Jul 1. doi: 10.1007/s10620-025-09180.
    PubMed     Abstract available
    
    
    June 2025
27. ZHOU P, Fu Y, Lu J, Liu Y, et al
    Crohn's Disease Combined with Complex Anal Fistula and Anorectal Stenosis.
    Dig Dis Sci. 2025 Jun 28. doi: 10.1007/s10620-025-09192.
    PubMed    
    
    
    
28. IYENGAR M, Jain A, Herfarth HH, Long MD, et al
    MUSings on a Crohn's Disease Diagnosis.
    Dig Dis Sci. 2025 Jun 26. doi: 10.1007/s10620-025-09160.
    PubMed    
    
    
    
29. CLARKE LM, Gupta S, Winter HS, Ryan DP, et al
    Sound of Success: Intestinal Ultrasound in the Management of Refractory Stricturing Crohn's Disease.
    Dig Dis Sci. 2025 Jun 25. doi: 10.1007/s10620-025-09172.
    PubMed     Abstract available
    
    
    
30. BORRAS-BLASCO J, Valcuende-Rosique A, Cornejo S
    Comment on "Switching to Subcutaneous Infliximab Maintenance Therapy is Effective in Patients with Inflammatory Bowel Disease".
    Dig Dis Sci. 2025 Jun 23. doi: 10.1007/s10620-025-09171.
    PubMed    
    
    
    
31. SODERHOLM JD
    Adding Fat to the Fire: Does Lipidated IL-22 Promote Mucosal Healing in Patients with Inflammatory Bowel Disease Treated with Immunomodulators?
    Dig Dis Sci. 2025 Jun 23. doi: 10.1007/s10620-025-09169.
    PubMed    
    
    
    
32. HAYEK ME, Chehade NEH, Mourad FH, Shen B, et al
    Radiation Therapy for Abdominal or Pelvic Cancer Treatment in Patients with Inflammatory Bowel Disease: A Systematic Review.
    Dig Dis Sci. 2025 Jun 17. doi: 10.1007/s10620-025-09128.
    PubMed     Abstract available
    
    
    
33. LOEB L, Farraye FA, Crosby S, Loftus EV Jr, et al
    Patients with Crohn's Disease and Ileostomy Can Respond to Upadacitinib.
    Dig Dis Sci. 2025 Jun 14. doi: 10.1007/s10620-025-09125.
    PubMed     Abstract available
    
    
    
34. VALLE NP, Hamidi S, Rodriguez F, Limketkai BN, et al
    Cerebral Crohn's Disease-Not Your Typical Brain-Gut Connection.
    Dig Dis Sci. 2025 Jun 13. doi: 10.1007/s10620-025-09150.
    PubMed    
    
    
    
35. MATAR A, Abdelnaem N, Camilleri M
    Bone Broth Benefits: How Its Nutrients Fortify Gut Barrier in Health and Disease.
    Dig Dis Sci. 2025;70:1951-1961.
    PubMed     Abstract available
    
    
    
36. STOY S, D'Alessio S, Sandahl TD, Dige A, et al
    Lipidated IL-22 Alone or Combined with Immunomodulatory Agents Improves Disease Endpoints and Promotes Mucosal Healing in a Mouse Model of Chronic Dextran Sodium Sulfate-Induced Colitis.
    Dig Dis Sci. 2025;70:2021-2031.
    PubMed     Abstract available
    
    
    May 2025
37. CHAEMSUPAPHAN T, Limsrivilai J
    Ustekinumab Dose Optimization in Ulcerative Colitis: Is More Always Better?
    Dig Dis Sci. 2025 May 31. doi: 10.1007/s10620-025-09108.
    PubMed    
    
    
    
38. OBAIDULLAH Z, Hassan MB, Fatima M, Kumar A, et al
    Adipokine Profiles and Their Association with Body Composition and Disease Activity in Pediatric Crohn's Disease.
    Dig Dis Sci. 2025 May 22. doi: 10.1007/s10620-025-09104.
    PubMed    
    
    
    
39. O'DONNELL JEM, Leach ST, Bowcock NL, Chen S, et al
    Correction: Daily Vitamin D3 Versus Stoss Vitamin D3 for Correction of 25OHD Deficiency in Children with Inflammatory Bowel Disease, a Randomised Controlled Trial.
    Dig Dis Sci. 2025 May 19. doi: 10.1007/s10620-025-09061.
    PubMed    
    
    
    
40. FEAGINS LA, Reveles KR
    Weighing the Consequences: Can Patients with Inflammatory Bowel Disease Jump on the GLP-1 Bandwagon?
    Dig Dis Sci. 2025 May 17. doi: 10.1007/s10620-025-09088.
    PubMed    
    
    
    
41. LIU GXH, Day AS
    Alpha Fail: Ustekinumab to the Rescue After TNFalpha Failure in Patients with Moderate to Severe Crohn's Disease.
    Dig Dis Sci. 2025 May 10. doi: 10.1007/s10620-025-09090.
    PubMed    
    
    
    
42. OWAIS M, Malani AK, Ameer F, Siddique A, et al
    Comments on "Evaluation of an Exercise Program in Patients with Inflammatory Bowel Disease: A Pilot Study".
    Dig Dis Sci. 2025 May 2. doi: 10.1007/s10620-025-09085.
    PubMed    
    
    
    April 2025
43. BAHIRWANI J, Elmer J, Eskarous H, Jai Kumar Ahuja S, et al
    Frailty Prevalence and Evaluation of the FRAIL Scale Questionnaire in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2025 Apr 29. doi: 10.1007/s10620-025-09073.
    PubMed     Abstract available
    
    
    
44. LIM Y, Park B, Jeon K, Jeong OS, et al
    Annual Therapeutic Drug Monitoring in Patients with Inflammatory Bowel Disease During Infliximab Maintenance Therapy: Balancing Efficacy with Risk of Pharmacokinetic Failure.
    Dig Dis Sci. 2025 Apr 29. doi: 10.1007/s10620-025-09032.
    PubMed     Abstract available
    
    
    
45. MAGEN-RIMON R, Cohen M, Rosen I, Spector-Cohen I, et al
    Adipokine Profiles and Their Association with Body Composition and Disease Activity in Pediatric Crohn's Disease.
    Dig Dis Sci. 2025 Apr 29. doi: 10.1007/s10620-025-08941.
    PubMed     Abstract available
    
    
    
46. ZHANG D, Sun Y, Wang J
    Transanal Opening of the Intersphincteric Space (TROPIS): Combined with Suture-Dragging for Treating of Rectovaginal and Perianal Fistulas in Crohn's Disease with Anorectal Stricture.
    Dig Dis Sci. 2025 Apr 28. doi: 10.1007/s10620-025-09059.
    PubMed    
    
    
    
47. ZHENG W, Kiran RP, Shen B
    Endoscopic Therapy for Anastomotic Bleeding in Inflammatory Bowel Disease.
    Dig Dis Sci. 2025 Apr 25. doi: 10.1007/s10620-025-09029.
    PubMed     Abstract available
    
    
    
48. PARK J, Kim S, Im JP, Lee HJ, et al
    Clinical Outcome of Inflammatory Bowel Disease with Clostridioides difficile Polymerase Chain Reaction Toxin-Positive/Enzyme Immunoassay Toxin-Negative: A Retrospective Cohort Study.
    Dig Dis Sci. 2025 Apr 21. doi: 10.1007/s10620-025-09045.
    PubMed     Abstract available
    
    
    
49. SETHI S, Puri R, Jain HP, Ashwin DK, et al
    A Rare Cause of Terminal Ileal Ulcer: Beyond Tuberculosis and Crohn's Disease.
    Dig Dis Sci. 2025 Apr 18. doi: 10.1007/s10620-025-09023.
    PubMed    
    
    
    
50. VAN DE POL N, Visser EH, van Noord D, van der Woude CJ, et al
    Evaluation of an Exercise Program in Patients with Inflammatory Bowel Disease: A Pilot Study.
    Dig Dis Sci. 2025 Apr 17. doi: 10.1007/s10620-025-09030.
    PubMed     Abstract available
    
    
    
51. OOMKENS D, Mujagic Z, de Vries A, van der Meulen-de Jong A, et al
    Obesity Is Associated with Inferior Clinical Treatment Outcomes in Inflammatory Bowel Disease: A Nationwide Dutch Registry Study.
    Dig Dis Sci. 2025 Apr 16. doi: 10.1007/s10620-025-09052.
    PubMed     Abstract available
    
    
    
52. SAWAF B, Abbarh S, Alsoud D
    Mirikizumab for Ulcerative Colitis: A Game-Changer or Just Another Incremental Advance?
    Dig Dis Sci. 2025 Apr 16. doi: 10.1007/s10620-025-09047.
    PubMed    
    
    
    
53. ALSAKARNEH S, Camilleri M, Farraye FA, Hashash JG, et al
    Comparative Effectiveness of Bile Acid Sequestrants and Antibiotics in the Management of Acute Pouchitis: A Matched Cohort Study from the United States.
    Dig Dis Sci. 2025 Apr 16. doi: 10.1007/s10620-025-09039.
    PubMed     Abstract available
    
    
    
54. VLADIMIROVA N, Zhao M, Ornbjerg LM, Moller JM, et al
    Musculoskeletal Symptoms and Clinical Findings in Bio-naive Patients with Inflammatory Bowel Disease Prior to Biological Treatment Initiation: A Prospective Cohort Study.
    Dig Dis Sci. 2025 Apr 15. doi: 10.1007/s10620-025-09016.
    PubMed     Abstract available
    
    
    
55. ABDELMEGUID A, El Banna AA, Elsheikh W, Ellakany AI, et al
    Evaluation of Acute Severe Ulcerative Colitis Predictors for Steroid Therapy Refractoriness.
    Dig Dis Sci. 2025 Apr 5. doi: 10.1007/s10620-025-08982.
    PubMed     Abstract available
    
    
    
56. TOMASIC V
    Seeing Is Believing: Does Red Dichromatic Imaging (RDI) Predict Histological Remission and Clinical Outcomes in Ulcerative Colitis Patients?
    Dig Dis Sci. 2025 Apr 3. doi: 10.1007/s10620-025-09027.
    PubMed    
    
    
    
57. POSTILL G, Im JHB, Tang F, Benchimol EI, et al
    Unmet Healthcare Needs Among People with Inflammatory Bowel Disease: A Canadian Cross-Sectional Population-Representative Study.
    Dig Dis Sci. 2025 Apr 2. doi: 10.1007/s10620-025-09015.
    PubMed     Abstract available
    
    
    
58. MULANAX C, Velayos FS
    Acute Severe Ulcerative Colitis in the Modern Era Spotlight on Opioids, Small Molecule Therapy, and Interdisciplinary Communication.
    Dig Dis Sci. 2025 Apr 2. doi: 10.1007/s10620-025-08947.
    PubMed    
    
    
    
59. LIAVA C, Chourmouzi D, Sinakos E, Dimitroulas T, et al
    Prevalence, Clinical Features, and Extraintestinal Manifestations in Patients with Familial Inflammatory Bowel Diseases.
    Dig Dis Sci. 2025;70:1467-1476.
    PubMed     Abstract available
    
    
    
60. HONAP S, Caron B, Ollech JE, Fischman M, et al
    Anti-tumor Necrosis Factor Drug Concentration Is Not Associated with Disease Outcomes in Pouchitis: A Retrospective, International Study.
    Dig Dis Sci. 2025;70:1320-1327.
    PubMed     Abstract available
    
    
    March 2025
61. LIN CJ, Chiang YC, Su TH, Shih IL, et al
    A Case of Uterine Adenosarcoma and Colonic Endometriosis Masquerading as Inflammatory Bowel Disease.
    Dig Dis Sci. 2025 Mar 21. doi: 10.1007/s10620-025-08988.
    PubMed     Abstract available
    
    
    
62. DANPANICHKUL P, Pang Y, Vuthithammee C, Dejvajara D, et al
    Older Adults with Inflammatory Bowel Disease Epidemiology in the United States: 2000-2021.
    Dig Dis Sci. 2025 Mar 19. doi: 10.1007/s10620-025-08976.
    PubMed     Abstract available
    
    
    
63. LATRAS-CORTES I, Saez Hortelano JC, Suarez-Alvarez P, Cano-Sanz N, et al
    Persistence and Efficacy of Ustekinumab in Crohn's Disease After Anti-TNF Failure: An Observational Study.
    Dig Dis Sci. 2025 Mar 19. doi: 10.1007/s10620-025-08978.
    PubMed     Abstract available
    
    
    
64. VAN LIEROP LMA, Albino L, Rosentreter R, Thomas PWA, et al
    Long-Term Effectiveness and Safety of Ustekinumab Dose Escalation in Patients with Moderate-to-Severe Ulcerative Colitis: A Multicenter Retrospective Cohort Study.
    Dig Dis Sci. 2025 Mar 17. doi: 10.1007/s10620-025-08977.
    PubMed     Abstract available
    
    
    
65. MOTWANI KK, Alizadeh M, Abutaleb A, Grossman J, et al
    Correction to: Correlation Between Serum and Fecal Biomarkers and Patient?Reported Outcomes in Patients with Crohn's Disease and Ulcerative Colitis.
    Dig Dis Sci. 2025 Mar 13. doi: 10.1007/s10620-025-08963.
    PubMed    
    
    
    
66. VERNON-ROBERTS A, Day AS
    Concise Commentary: Do Population Migrations Affect the Incidence, Severity, and Outcomes of Inflammatory Bowel Disease?
    Dig Dis Sci. 2025 Mar 12. doi: 10.1007/s10620-025-08972.
    PubMed    
    
    
    
67. LIU Y, Sun Y, Zhou P, Wang J, et al
    Transanal Opening of the Intersphincteric Space (TROPIS) Combined with Suture-Dragging for Complex Rectovaginal Fistula (RVF) with Anorectal Stenosis in Crohn's Disease.
    Dig Dis Sci. 2025 Mar 12. doi: 10.1007/s10620-025-08967.
    PubMed    
    
    
    
68. CLARKE L, Passam RT, Falahee B, Jirapinyo P, et al
    Tolerability and Effectiveness of Glucagon-Like Peptide-1 Receptor Agonists in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2025 Mar 11. doi: 10.1007/s10620-025-08964.
    PubMed     Abstract available
    
    
    
69. BOURGONJE AR, Kayal M
    Understanding the Impact of Prior Anti-TNF Exposure on Colectomy Risk in Acute Severe Ulcerative Colitis.
    Dig Dis Sci. 2025 Mar 6. doi: 10.1007/s10620-025-08930.
    PubMed    
    
    
    
70. ST-PIERRE J, Choi D, Fear E, Choi NK, et al
    Mirikizumab in the Treatment of Ulcerative Colitis: Initial Real-World Data in a Population from a Large Tertiary Center.
    Dig Dis Sci. 2025 Mar 6. doi: 10.1007/s10620-025-08950.
    PubMed     Abstract available
    
    
    
71. DAI C, Su XY
    Association Between Prior Anti-TNF Exposure and Colectomy in Acute Severe Ulcerative Colitis.
    Dig Dis Sci. 2025 Mar 5. doi: 10.1007/s10620-025-08891.
    PubMed    
    
    
    
72. MALIK S, Naqvi SAA, Shadali AH, Khan H, et al
    Fecal Microbiota Transplantation (FMT) and Clinical Outcomes Among Inflammatory Bowel Disease (IBD) Patients: An Umbrella Review.
    Dig Dis Sci. 2025 Mar 4. doi: 10.1007/s10620-025-08946.
    PubMed     Abstract available
    
    
    
73. AHSAN M, Udaikumar J, Hong S, Faye AS, et al
    The Impact of Concomitant Hypothyroid Disease on the Course of Inflammatory Bowel Disease.
    Dig Dis Sci. 2025 Mar 1. doi: 10.1007/s10620-025-08956.
    PubMed     Abstract available
    
    
    
74. YOUSSEF M, Tandon P, Jones T, Srikanth V, et al
    Key Themes in the Care of Inflammatory Bowel Diseases Among Immigrant Populations: A Systematic Review.
    Dig Dis Sci. 2025;70:1016-1033.
    PubMed     Abstract available
    
    
    
75. KAUNITZ JD
    Sometimes Small Is Beautiful: Discovery of the Janus Kinases (JAK) and Signal Transducer and Activator of Transcription (STAT) Pathways and the Initial Development of JAK Inhibitors for IBD Treatment.
    Dig Dis Sci. 2025;70:890-898.
    PubMed     Abstract available
    
    
    
76. POWERS JC, Dester E, Schleicher M, Cohen B, et al
    Medical, Endoscopic, and Surgical Treatments for Rectal Cuffitis in IBD Patients with an Ileal Pouch-Anal Anastomosis: A Narrative Review.
    Dig Dis Sci. 2025;70:943-963.
    PubMed     Abstract available
    
    
    
77. CLAYTOR JD, Lin DL, Magnaye KM, Guerrero YS, et al
    Effect of Fecal Microbiota Transplant on Antibiotic Resistance Genes Among Patients with Chronic Pouchitis.
    Dig Dis Sci. 2025;70:982-990.
    PubMed     Abstract available
    
    
    February 2025
78. OWINGS AH, Glover SC, Cheifetz AS, Papamichael K, et al
    Delays in Utilizing Biological Therapy Is a Global Reality and May Lead to Negative Outcomes in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2025 Feb 28. doi: 10.1007/s10620-025-08920.
    PubMed    
    
    
    
79. O'DONNELL JEM, Leach ST, Bowcock NL, Chen S, et al
    Daily Vitamin D3 Versus Stoss Vitamin D3 for Correction of 25OHD Deficiency in Children with Inflammatory Bowel Disease, a Randomised Controlled Trial.
    Dig Dis Sci. 2025 Feb 28. doi: 10.1007/s10620-025-08913.
    PubMed     Abstract available
    
    
    
80. CAVE DR, Hanscom M, Bledsoe J, Madahian S, et al
    Chronic Stenosing Enteritis: A Variant of Chronic Non-specific Stenosing Ulceration (CNSU) that Is Distinct from Crohn's Disease.
    Dig Dis Sci. 2025 Feb 22. doi: 10.1007/s10620-024-08815.
    PubMed     Abstract available
    
    
    
81. SUN Y, Liu Y, Zhou P, Yang M, et al
    Transanal Opening of the Intersphincteric Space (TROPIS) for Managing High Complex Perianal Fistula in a Crohn's Disease Case with Anorectal Stenosis.
    Dig Dis Sci. 2025 Feb 18. doi: 10.1007/s10620-025-08859.
    PubMed    
    
    
    
82. VASUDEVAN J, Mukkamala B, Dhother B, Guzik P, et al
    Delayed Corticosteroid Treatment for Patients Requiring Hospitalization for Acute Inflammatory Bowel Disease Exacerbations Increases Length of Stay and Risk for Surgery in Crohn's Disease.
    Dig Dis Sci. 2025 Feb 13. doi: 10.1007/s10620-025-08907.
    PubMed     Abstract available
    
    
    
83. RAUTAKORPI J, Kolehmainen S, Loyttyniemi E, Bjorkesten CA, et al
    Switching to Subcutaneous Infliximab Maintenance Therapy Is Effective in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2025 Feb 13. doi: 10.1007/s10620-025-08876.
    PubMed     Abstract available
    
    
    
84. FANSIWALA K, Sauk JS
    Small Molecules, Big Results: How JAK Inhibitors Have Transformed the Treatment of Patients with IBD.
    Dig Dis Sci. 2025;70:469-477.
    PubMed     Abstract available
    
    
    January 2025
85. MAMIYA Y, Taida T, Kato J, Matsusaka K, et al
    Usefulness of Novel Image-Enhanced Endoscopy for Predicting Maintenance of Clinical Remission in Ulcerative Colitis.
    Dig Dis Sci. 2025 Jan 27. doi: 10.1007/s10620-025-08849.
    PubMed     Abstract available
    
    
    
86. WATSON KL JR
    Calling in Your Markers: Can Biomarkers Predict the Response to Anti-TNF Therapy in Pediatric Patients with Crohn's Disease?
    Dig Dis Sci. 2025 Jan 24. doi: 10.1007/s10620-025-08856.
    PubMed    
    
    
    
87. TARASSISHIN L, Kim T, Hu J, Barre A, et al
    Elevated Fecal Lipocalin-2 Levels During Early Life Are Associated with Maternal Inflammatory Bowel Disease Diagnosis.
    Dig Dis Sci. 2025 Jan 24. doi: 10.1007/s10620-025-08864.
    PubMed     Abstract available
    
    
    
88. KURIAKOSE KUZHIYANJAL AJ, Subramanian S, Limdi JK
    Delays in Initiating Biologic Therapy in Patients with Inflammatory Bowel Disease-Perception and Reality.
    Dig Dis Sci. 2025 Jan 22. doi: 10.1007/s10620-025-08855.
    PubMed    
    
    
    
89. KRISHNA M, Spartz EJ, Maas L, Cusumano V, et al
    Retrospective Cohort Study on the Predictive Value of Primary Non-response to Initial Biologic for Future Biologic Use in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2025 Jan 4. doi: 10.1007/s10620-024-08816.
    PubMed     Abstract available
    
    
    
90. JAVAID SS, Akhtar S, Hafeez A, Nofal A, et al
    Trends in Mortality Due to Inflammatory Bowel Disease in the United States: A CDC WONDER Database Analysis (1999-2020).
    Dig Dis Sci. 2025 Jan 2. doi: 10.1007/s10620-024-08803.
    PubMed     Abstract available
    
    
    
91. FORBES AJ, Day AS, Frampton CMA, Gearry RB, et al
    Incidence of Inflammatory Bowel Disease in Canterbury, New Zealand, 2018-2023.
    Dig Dis Sci. 2025 Jan 2. doi: 10.1007/s10620-024-08811.
    PubMed     Abstract available
    
    
    
92. BOURGONJE AR, Posner H, Carbonnel F, Colombel JF, et al
    Prior Anti-TNF Exposure Is Associated with an Increased Risk of Short- and Long-Term Colectomy in Acute Severe Ulcerative Colitis.
    Dig Dis Sci. 2025 Jan 2. doi: 10.1007/s10620-024-08809.
    PubMed     Abstract available
    
    
    
93. SANDYS O, Stokkers PCF, Te Velde AA
    DAMP-ing IBD: Extinguish the Fire and Prevent Smoldering.
    Dig Dis Sci. 2025;70:49-73.
    PubMed     Abstract available
    
    
    December 2024
94. YANOVER C, Magen-Rimon R, Voss EA, Swerdel J, et al
    Characteristics and Outcomes of Over a Million Patients with Inflammatory Bowel Disease in Seven Countries: Multinational Cohort Study and Open Data Resource.
    Dig Dis Sci. 2024 Dec 26. doi: 10.1007/s10620-024-08787.
    PubMed     Abstract available
    
    
    
95. DUPENLOUP P, Zhou M, Dizon MP, Shah AP, et al
    Therapeutic Drug Monitoring in Patients with Ulcerative Colitis on Infliximab: A Cost-Effectiveness Analysis.
    Dig Dis Sci. 2024 Dec 26. doi: 10.1007/s10620-024-08802.
    PubMed     Abstract available
    
    
    
96. NARANG H, Kedia S
    Expanding Options for Endoscopic Therapy of Strictures in Patients with Inflammatory Bowel Disease: Is Stricturotomy the Best?
    Dig Dis Sci. 2024 Dec 13. doi: 10.1007/s10620-024-08726.
    PubMed    
    
    
    November 2024
97. GALTS C, Siempelkamp B, Duthie K, Wilson L, et al
    Informing Modern Models of Care: A Randomized, Sequential Trial of In-Person, Telehealth, and Telephone Appointments for Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2024 Nov 29. doi: 10.1007/s10620-024-08750.
    PubMed     Abstract available
    
    
    
98. JIANG Y, Shi R, Zhou P, Lei Y, et al
    Application Value of Endoscopic Ultrasonography in Diagnosis and Treatment of Inflammatory Bowel Disease.
    Dig Dis Sci. 2024 Nov 29. doi: 10.1007/s10620-024-08751.
    PubMed     Abstract available
    
    
    
99. LISAI-GOLDSTEIN Y, Focht G, Orlanski-Meyer E, Yogev D, et al
    Serological Markers as Predictors of Anti-TNF Response in Children with Crohn's Disease.
    Dig Dis Sci. 2024 Nov 27. doi: 10.1007/s10620-024-08732.
    PubMed     Abstract available
    
    
    
100. YOUN J, Hsia K, Khadilkar S, Zeina T, et al
     The Impact of Obesity on the Prevalence and Complications of Perianal Fistulas of Crohn's Disease.
     Dig Dis Sci. 2024 Nov 16. doi: 10.1007/s10620-024-08729.
     PubMed     Abstract available
     
     
     
101. SHEEHAN JL, Jordan AA, Newman KL, Johnson LA, et al
     Disparities in Vaccination Amongst Socially Vulnerable Patients with Inflammatory Bowel Disease.
     Dig Dis Sci. 2024 Nov 15. doi: 10.1007/s10620-024-08733.
     PubMed     Abstract available
     
     
     
102. NIELSEN KR, Modin FA, Midjord J, Vang A, et al
     Comparing Environmental Risk Factors at Diagnosis in Faroese and Danish Patients with Inflammatory Bowel Disease.
     Dig Dis Sci. 2024 Nov 14. doi: 10.1007/s10620-024-08721.
     PubMed     Abstract available
     
     
     
103. KLEMM N, Moosavi S
     Chronic Abdominal Pain in Patients with Inflammatory Bowel Disease in Remission: A Continuing Challenge for Clinicians.
     Dig Dis Sci. 2024 Nov 13. doi: 10.1007/s10620-024-08716.
     PubMed     Abstract available
     
     
     
104. ST-PIERRE J, Klein J, Choi NK, Fear E, et al
     Efficacy and Safety of GLP-1 Agonists on Metabolic Parameters in Non-diabetic Patients with Inflammatory Bowel Disease.
     Dig Dis Sci. 2024 Nov 8. doi: 10.1007/s10620-024-08720.
     PubMed     Abstract available
     
     
     
105. VERNON-ROBERTS A, Blay L, Day AS
     Inflammatory Bowel Disease Knowledge and Education Among Healthcare Professional Groups.
     Dig Dis Sci. 2024 Nov 4. doi: 10.1007/s10620-024-08719.
     PubMed    
     
     
     
106. EAR S, Cordero J, McConnell R, Velayos F, et al
     Extended Monitoring for Transition to Oral Corticosteroids in Acute Severe Ulcerative Colitis May Be Unnecessarily Prolonging Length of Stay.
     Dig Dis Sci. 2024 Nov 4. doi: 10.1007/s10620-024-08679.
     PubMed     Abstract available
     
     
     October 2024
107. SHEEHAN JL, Greene-Higgs L, Resnicow K, Patel MR, et al
     Self-Efficacy, Patient Activation, and the Burden of Inflammatory Bowel Disease on Patients' Daily Lives.
     Dig Dis Sci. 2024 Oct 26. doi: 10.1007/s10620-024-08712.
     PubMed     Abstract available
     
     
     
108. CHEN L, Peng J, Wang Y, Liu Y, et al
     FMT Combined with Vedolizumab for the Treatment of Refractory Ulcerative Colitis.
     Dig Dis Sci. 2024 Oct 26. doi: 10.1007/s10620-024-08666.
     PubMed    
     
     
     
109. MEMEL Z, Thiemann A, Dort C, Mahadevan U, et al
     Prevalence of Malnutrition and Micronutrient Deficiencies in Older Adults with Ulcerative Colitis.
     Dig Dis Sci. 2024 Oct 22. doi: 10.1007/s10620-024-08650.
     PubMed     Abstract available
     
     
     
110. FAN Y, Zhang L, Omidakhsh N, Bohn RL, et al
     Progression of Crohn's Disease in Newly Diagnosed Patients: Results from an Observational Study Using US Claims Data.
     Dig Dis Sci. 2024 Oct 22. doi: 10.1007/s10620-024-08591.
     PubMed     Abstract available
     
     
     
111. DEMERS K, Bongers BC, van Kuijk SMJ, Plasqui G, et al
     Criterion Validity of Screening Tools and Field-Based Tests for Health-Related Physical Fitness in Inflammatory Bowel Disease.
     Dig Dis Sci. 2024 Oct 19. doi: 10.1007/s10620-024-08682.
     PubMed     Abstract available
     
     
     
112. MOTWANI K, Cohen E, Liang JJ, Cross RK, et al
     Heartaches and Gut Feelings: Exploring Myocarditis in Crohn's Disease.
     Dig Dis Sci. 2024 Oct 12. doi: 10.1007/s10620-024-08674.
     PubMed    
     
     
     
113. UKASHI O, Dotan A, Borkovsky T, Talan Asher A, et al
     Pro-motility Preparation Protocol May Reduce the Rates of Failed Patency Capsule Among Patients with Crohn's Disease in Clinical Remission.
     Dig Dis Sci. 2024 Oct 9. doi: 10.1007/s10620-024-08670.
     PubMed     Abstract available
     
     
     
114. SHA L, Cao J, Yang Y, Wang J, et al
     5-Aminosalicylic Acid Aggravates Bloody Diarrhoea in Crohn's Disease.
     Dig Dis Sci. 2024 Oct 3. doi: 10.1007/s10620-024-08658.
     PubMed    
     
     
     
115. YU X, Li C, Tao Y, Xia T, et al
     Lacidipine Inhibits NF-kappaB and Notch Pathways and Mitigates DSS-Induced Colitis.
     Dig Dis Sci. 2024;69:3753-3759.
     PubMed     Abstract available
     
     
     
116. YE K, Jin Z, Chen Q, Cen L, et al
     Natural History and Longitudinal Outcomes of Patients with Mild-to-Moderate Ulcerative Proctitis or Ulcerative Proctosigmoiditis: A Single-Center, Retrospective Study.
     Dig Dis Sci. 2024;69:3701-3709.
     PubMed     Abstract available
     
     
     September 2024
117. PRINCIPI M, Brescia IV, Stasi E, Mazzuoli S, et al
     Transition to Subcutaneous Infliximab vs Vedolizumab in Inflammatory Bowel Disease: A Prospective Multicenter Study.
     Dig Dis Sci. 2024 Sep 30. doi: 10.1007/s10620-024-08631.
     PubMed     Abstract available
     
     
     
118. YANG JC, Zhao M, Chernikova D, Arias-Jayo N, et al
     ZIP8 A391T Crohn's Disease-Linked Risk Variant Induces Colonic Metal Ion Dyshomeostasis, Microbiome Compositional Shifts, and Inflammation.
     Dig Dis Sci. 2024 Sep 25. doi: 10.1007/s10620-024-08647.
     PubMed     Abstract available
     
     
     
119. DRYGIANNAKIS I, Valatas V, Filidou E, Tzenaki N, et al
     Low-Grade Activation of the Extrinsic Coagulation Pathway in Patients with Ulcerative Colitis.
     Dig Dis Sci. 2024 Sep 25. doi: 10.1007/s10620-024-08640.
     PubMed     Abstract available
     
     
     
120. GONG Y, He Y, Wan M, Chen H, et al
     Risk Factors for Gallstones in Crohn's Disease: A Systematic Review and Meta-Analysis.
     Dig Dis Sci. 2024 Sep 25. doi: 10.1007/s10620-024-08597.
     PubMed     Abstract available
     
     
     
121. ROMAIN D, Larson C, Kathuria P, Aintabi D, et al
     Understanding the Perspectives and Experiences of Patients with Acute Severe Ulcerative Colitis in the Hospital: A Qualitative Analysis.
     Dig Dis Sci. 2024 Sep 18. doi: 10.1007/s10620-024-08633.
     PubMed     Abstract available
     
     
     
122. NEWLAND JJ, Sundel MH, Blackburn KW, Vessilenov R, et al
     Association of Race and Postoperative Outcomes in Patients with Inflammatory Bowel Disease.
     Dig Dis Sci. 2024 Sep 11. doi: 10.1007/s10620-024-08594.
     PubMed     Abstract available
     
     
     
123. ODAH T, Karime C, Desai A, Picco MF, et al
     Response to Upadacitinib in Patients with Inflammatory Bowel Disease Previously Treated with Tofacitinib.
     Dig Dis Sci. 2024 Sep 9. doi: 10.1007/s10620-024-08630.
     PubMed     Abstract available
     
     
     
124. ESCHER JC
     Transition or Transfer Readiness in Young Patients with IBD: What Does It Really Mean? : Invited commentary on Khan SM et al, A Smooth Transition: Assessing Transition Readiness In Adolescents with Inflammatory Bowel Disease (2024).
     Dig Dis Sci. 2024 Sep 9. doi: 10.1007/s10620-024-08624.
     PubMed    
     
     
     
125. CLARKE LM, Riascos MC, Redston MS, Hamilton MJ, et al
     Ileal Signet Ring Adenocarcinoma in Crohn's Disease: Unanticipated Diagnosis After Surgical Resection of a Symptomatic Stricture.
     Dig Dis Sci. 2024 Sep 9. doi: 10.1007/s10620-024-08621.
     PubMed    
     
     
     
126. GRAY C, Shakir R, Tumin D, Mandelia C, et al
     Predictors of Unplanned Health Care Utilization Among Children with Inflammatory Bowel Disease in a Rural Region of the Southeastern US.
     Dig Dis Sci. 2024 Sep 3. doi: 10.1007/s10620-024-08619.
     PubMed     Abstract available
     
     
     
127. FORBES AJ
     Westernization and the Hazards of a "Taipei Personality"-Will the Incidence of IBD in Taiwan Catch Up with the West?
     Dig Dis Sci. 2024;69:3112-3113.
     PubMed    
     
     
     
128. PAN Y, Lilly E, Ananthakrishnan AN
     Risk Factors for the Development of and Outcomes After Diagnosis of Autoimmune Alopecia Areata in Patients with Inflammatory Bowel Diseases.
     Dig Dis Sci. 2024;69:3375-3381.
     PubMed     Abstract available
     
     
     
129. KUO CJ, Lin CY, Le PH, Kuo YW, et al
     Temporal Trends of Inflammatory Bowel Diseases in Taiwan from 2016 to 2020: A Population-Based Study.
     Dig Dis Sci. 2024;69:3172-3179.
     PubMed     Abstract available
     
     
     August 2024
130. CHEN KA, Gartner V, Darlington KC, Silverstein SR, et al
     Post-operative Crohn's Disease Recurrence and Infectious Complications: A Transcriptomic Analysis.
     Dig Dis Sci. 2024 Aug 31. doi: 10.1007/s10620-024-08595.
     PubMed     Abstract available
     
     
     
131. HARINDRANATH S
     Tofacitinib in Ulcerative Colitis - Second-Line Therapy, First-Rate Results.
     Dig Dis Sci. 2024 Aug 22. doi: 10.1007/s10620-024-08589.
     PubMed    
     
     
     
132. HORIUCHI K, Higashiyama M, Tahara H, Yoshidome Y, et al
     Absence of Paneth Cell Metaplasia to Predict Clinical Relapse in Ulcerative Colitis with Endoscopically Quiescent Mucosa.
     Dig Dis Sci. 2024 Aug 7. doi: 10.1007/s10620-024-08581.
     PubMed     Abstract available
     
     
     
133. HORWELL E, Vittoria M, Hong HA, Bearn P, et al
     A Family of Cyclic Lipopeptides Found in Human Isolates of Bacillus Ameliorates Acute Colitis via Direct Agonism of Toll-Like Receptor 2 in a Murine Model of Inflammatory Bowel Disease.
     Dig Dis Sci. 2024 Aug 7. doi: 10.1007/s10620-024-08534.
     PubMed     Abstract available
     
     
     
134. ZHANG P, Zhang C, Chen B, He Y, et al
     Assessment of Endoscopy-Based Scoring Systems for Prognostication in Ulcerative Colitis: A Comparative Analysis.
     Dig Dis Sci. 2024 Aug 6. doi: 10.1007/s10620-024-08582.
     PubMed     Abstract available
     
     
     
135. GNANAPANDITHAN K, Stuessel LG, Shen B, Mourad FH, et al
     Pelvic Radiation Therapy Increases Risk of Pouch Failure in Patients with Inflammatory Bowel Disease and Ileal Pouch.
     Dig Dis Sci. 2024 Aug 1. doi: 10.1007/s10620-024-08576.
     PubMed     Abstract available
     
     
     
136. HSU WC, Chen CM, Kuo CJ, Tsou YK, et al
     Upper Gastrointestinal Involvement in Crohn's Disease as an Independent Predictor of New-Onset Strictures: Insights from an Extensive Retrospective Cohort Analysis.
     Dig Dis Sci. 2024 Aug 1. doi: 10.1007/s10620-024-08577.
     PubMed     Abstract available
     
     
     
137. LOCKMAN S, Tandon P
     Low-Dose Aspirin Use in Pregnancy in Patients with IBD with Risk Factors for Preeclampsia: A Retrospective Cohort Study.
     Dig Dis Sci. 2024;69:2719-2720.
     PubMed    
     
     
     
138. MAHMOUD M, Syn WK
     Impact of Obesity and Metabolic Syndrome on IBD Outcomes.
     Dig Dis Sci. 2024;69:2741-2753.
     PubMed     Abstract available
     
     
     
139. ALPEREN CC, Soydas B, Serin E, Erbayrak M, et al
     Role of Environmental Risk Factors in the Etiology of Inflammatory Bowel Diseases: A Multicenter Study.
     Dig Dis Sci. 2024;69:2927-2936.
     PubMed     Abstract available
     
     
     July 2024
140. SIFFLEDEEN J, Hoentjen F
     Disparities in Advanced Therapy Initiation for Inflammatory Bowel Disease: Access Comes First.
     Dig Dis Sci. 2024 Jul 29. doi: 10.1007/s10620-024-08580.
     PubMed    
     
     
     
141. SWAMINATHAN A, Day AS
     Measures of Gut Inflammation in Patients with Inflammatory Bowel Disease: Are Blood-Based Biomarkers Sufficient?
     Dig Dis Sci. 2024 Jul 29. doi: 10.1007/s10620-024-08567.
     PubMed    
     
     
     
142. COHEN-MEKELBURG S, Johnson J, Paine E, Prasad MA, et al
     Assessment of Physician Needs and Access to Inflammatory Bowel Disease Specialty Care Resources in a National Integrated Health System.
     Dig Dis Sci. 2024 Jul 27. doi: 10.1007/s10620-024-08560.
     PubMed     Abstract available
     
     
     
143. MATHIEU K, Junda J, Minet-Quinard R, Coban D, et al
     Intestinal Ultrasonography as an Alternative to Fecal Calprotectin to Monitor Patients with Crohn's Disease: Experience from a Novice Sonographer.
     Dig Dis Sci. 2024 Jul 20. doi: 10.1007/s10620-024-08548.
     PubMed     Abstract available
     
     
     
144. ABADIR A, Troia A, Said H, Tarugu S, et al
     Factors Associated with Delays in Initiating Biologic Therapy in Patients with Inflammatory Bowel Disease.
     Dig Dis Sci. 2024 Jul 4. doi: 10.1007/s10620-024-08514.
     PubMed     Abstract available
     
     
     
145. MU J, Maeda K, Ohashi A, Urano T, et al
     Monoclonal Antibodies Against Mature Interleukin-18 Ameliorate Colitis and Repair Goblet Cell Function.
     Dig Dis Sci. 2024;69:2573-2585.
     PubMed     Abstract available
     
     
     June 2024
146. JABER F, Numan L, Ayyad M, Abuelazm M, et al
     Efficacy and Safety of Endoscopic Stricturotomy in Inflammatory Bowel Disease-Related Strictures: A Systematic Review and Meta-Analysis.
     Dig Dis Sci. 2024 Jun 26. doi: 10.1007/s10620-024-08533.
     PubMed     Abstract available
     
     
     
147. ZHOU P, Lu J, Zhang J, Wang J, et al
     Perianal Fistulizing Crohn's Disease Combined with Pilonidal Sinus and Hidradenitis Suppurativa.
     Dig Dis Sci. 2024 Jun 26. doi: 10.1007/s10620-024-08535.
     PubMed    
     
     
     
148. LEY D, Lazarus S, Forati AM, Farraye FA, et al
     High Rates of Seroprotection to Hepatitis B After a Hepatitis B Challenge Dose in Previously Vaccinated Patients with Inflammatory Bowel Disease on Immunosuppressive Therapy.
     Dig Dis Sci. 2024 Jun 21. doi: 10.1007/s10620-024-08527.
     PubMed     Abstract available
     
     
     
149. ALIZADEH M, Wong U, Siaton BC, Patil SA, et al
     Inflammatory Bowel Disease-Associated Arthritis Is Associated with Concomitant Autoimmune and Inflammatory Disorders.
     Dig Dis Sci. 2024 Jun 20. doi: 10.1007/s10620-024-08478.
     PubMed     Abstract available
     
     
     
150. TE VELDE AA
     Putting Crohn's Disease on the MAP: Potential Contribution of a "Stealth Pathogen".
     Dig Dis Sci. 2024 Jun 20. doi: 10.1007/s10620-024-08503.
     PubMed    
     
     
     
151. AGRAWAL G, Borody TJ, Aitken JM
     Mapping Crohn's Disease Pathogenesis with Mycobacterium paratuberculosis: A Hijacking by a Stealth Pathogen.
     Dig Dis Sci. 2024 Jun 19. doi: 10.1007/s10620-024-08508.
     PubMed     Abstract available
     
     
     
152. LOWELL JA, Sharma G, Chua V, Ben-Horin S, et al
     Reactive Immunomodulator Addition to Infliximab Monotherapy Restores Clinical Response in Inflammatory Bowel Disease: A Meta-Analysis.
     Dig Dis Sci. 2024 Jun 14. doi: 10.1007/s10620-024-08515.
     PubMed     Abstract available
     
     
     
153. BARNES A, Mukherjee S, Andrews JM, Spizzo P, et al
     Active Inflammatory Bowel Disease Is Associated with Short Sleep Duration via Objective Measures.
     Dig Dis Sci. 2024 Jun 6. doi: 10.1007/s10620-024-08485.
     PubMed     Abstract available
     
     
     
154. LORES T, Mikocka-Walus A, Andrews JM, Evans S, et al
     Psychological Care for People with Inflammatory Bowel Diseases: Exploring Consumers' Perspectives to Inform Future Service Co-design.
     Dig Dis Sci. 2024;69:1979-1989.
     PubMed     Abstract available
     
     
     May 2024
155. JANAK JC, Loughlin AM, Moore PC, Lemay CA, et al
     The Burden of Work Productivity and Activity Impairment in Patients with Psoriasis, Psoriatic Arthritis, Ulcerative Colitis, and Crohn's Disease.
     Dig Dis Sci. 2024 May 29. doi: 10.1007/s10620-024-08451.
     PubMed     Abstract available
     
     
     
156. COHEN NA, Choden T, Dyer EC, Garcia NM, et al
     Utility of the Endoscopic Healing Index in Identifying Active Inflammation in Patients with Crohn's Disease: Real World Data from a Tertiary Center.
     Dig Dis Sci. 2024 May 29. doi: 10.1007/s10620-024-08492.
     PubMed     Abstract available
     
     
     
157. MOSKOW J, Thurston T, Saleh A, Shah A, et al
     Postoperative Ustekinumab Drug Levels and Disease Activity in Patients with Crohn's Disease.
     Dig Dis Sci. 2024 May 24. doi: 10.1007/s10620-024-08471.
     PubMed     Abstract available
     
     
     
158. KHAN SM, Tuchman D, Imran A, Lakdawala FM, et al
     A Smooth Transition: Assessing Transition Readiness in Adolescents with Inflammatory Bowel Disease.
     Dig Dis Sci. 2024 May 23. doi: 10.1007/s10620-024-08484.
     PubMed     Abstract available
     
     
     
159. MOTWANI KK, Alizadeh M, Abutaleb A, Grossman J, et al
     Correction to: Correlation Between Plasma and Fecal Biomarkers and Patient?Reported Outcomes in Patients with Crohn's Disease and Ulcerative Colitis.
     Dig Dis Sci. 2024 May 16. doi: 10.1007/s10620-024-08469.
     PubMed    
     
     
     
160. EMERSON C, Skvarc D, Mikocka-Walus A, Olive L, et al
     People with Inflammatory Bowel Disease Prefer Cognitive Behavioral Therapy for Fatigue Management: A Conjoint Analysis.
     Dig Dis Sci. 2024 May 11. doi: 10.1007/s10620-024-08468.
     PubMed     Abstract available
     
     
     
161. MEDAWAR E, Djinbachian R, Crainic IP, Safih W, et al
     Serrated Polyps in Inflammatory Bowel Disease Indicate a Similar Risk of Metachronous Colorectal Neoplasia as in the General Population.
     Dig Dis Sci. 2024 May 3. doi: 10.1007/s10620-024-08456.
     PubMed     Abstract available
     
     
     
162. SCHREIBER S, Hunter Gibble T, Panaccione R, Rubin DT, et al
     Patient and Health Care Professional Perceptions of the Experience and Impact of Symptoms of Moderate-to-Severe Crohn's Disease in US and Europe: Results from the Cross-Sectional CONFIDE Study.
     Dig Dis Sci. 2024 May 3. doi: 10.1007/s10620-024-08434.
     PubMed     Abstract available
     
     
     
163. SIFFLEDEEN J, Singh S, Shulman SM, Igoe J, et al
     Effect of Suboptimal Disease Control on Patient Quality of Life: Real-World Data from the Observational IBD-PODCAST Canada Trial.
     Dig Dis Sci. 2024;69:1636-1648.
     PubMed     Abstract available
     
     
     April 2024
164. GREYWOODE R, Larson J, Peraza J, Clark R, et al
     Risk of Adverse Cardiovascular Outcomes in Postmenopausal Women with Inflammatory Bowel Disease.
     Dig Dis Sci. 2024 Apr 29. doi: 10.1007/s10620-024-08348.
     PubMed     Abstract available
     
     
     
165. LAMICHHANE N, Melas N, Bergqvist V, Ekholm NP, et al
     Real-World Outcomes of Patients Starting Intravenous and Transitioning to Subcutaneous Vedolizumab in Inflammatory Bowel Disease.
     Dig Dis Sci. 2024 Apr 18. doi: 10.1007/s10620-024-08422.
     PubMed     Abstract available
     
     
     
166. KANE K, Velayos FS, Lee JK, Cherny S, et al
     A Response-able Diagnosis: Type 2 Autoimmune Pancreatitis in the Setting of Ulcerative Colitis.
     Dig Dis Sci. 2024 Apr 18. doi: 10.1007/s10620-024-08408.
     PubMed    
     
     
     
167. VAN LINSCHOTEN RCA, Jansen FM, Pauwels RWM, Smits LJT, et al
     A Prediction Model for Successful Increase of Adalimumab Dose Intervals in Patients with Crohn's Disease: Secondary Analysis of the Pragmatic Open-Label Randomised Controlled Non-inferiority LADI Trial.
     Dig Dis Sci. 2024 Apr 9. doi: 10.1007/s10620-024-08410.
     PubMed     Abstract available
     
     
     
168. MOTWANI KK, Alizadeh M, Abutaleb A, Grossman J, et al
     Correlation Between Serum and Fecal Biomarkers and Patient-Reported Outcomes in Patients with Crohn's Disease and Ulcerative Colitis.
     Dig Dis Sci. 2024 Apr 5. doi: 10.1007/s10620-024-08421.
     PubMed     Abstract available
     
     
     
169. HARRIS S, Feagan BG, Hanauer S, Vermeire S, et al
     Ozanimod Differentially Impacts Circulating Lymphocyte Subsets in Patients with Moderately to Severely Active Crohn's Disease.
     Dig Dis Sci. 2024 Apr 3. doi: 10.1007/s10620-024-08391.
     PubMed     Abstract available
     
     
     
170. DJALAL A, Wong SY, Colombel JF, Ungaro R, et al
     Problem with Hookups: Perianal Fistula After Ileal Pouch-Anal Anastomosis.
     Dig Dis Sci. 2024;69:1102-1104.
     PubMed    
     
     
     
171. CLINTON J, Motwani KK, Schwartz S, McCarthy P, et al
     Upadacitinib as Rescue Therapy for the Treatment of Acute Severe Colitis in an Acute Care Setting.
     Dig Dis Sci. 2024;69:1105-1109.
     PubMed     Abstract available
     
     
     
172. SINGH A, Mahajan R, Midha V, Kaur K, et al
     Effectiveness of Tofacitinib in Ulcerative Proctitis Compared to Left Sided Colitis and Pancolitis.
     Dig Dis Sci. 2024;69:1389-1402.
     PubMed     Abstract available
     
     
     March 2024
173. FIELD J, Shah ND, Memel Z, Mahadevan U, et al
     Exclusive Yet Effective: The Crohn's Disease Exclusion Diet as Treatment for Medication-Refractory Disease.
     Dig Dis Sci. 2024 Mar 30. doi: 10.1007/s10620-024-08345.
     PubMed    
     
     
     
174. CARVALHAS GABRIELLI AM, Ferretti F, Monico CM, Tombetti E, et al
     Effect of Tofacitinib on One-Year Colectomy Risk in Anti-TNF Refractory Ulcerative Colitis: A Prospective Multicenter Italian Study.
     Dig Dis Sci. 2024 Mar 26. doi: 10.1007/s10620-024-08394.
     PubMed     Abstract available
     
     
     
175. KELLAR A, Dolinger MT, Spencer EA, Dubinsky MC, et al
     Real-World Outcomes of Dual Advanced Therapy in Children and Young Adults with Inflammatory Bowel Disease.
     Dig Dis Sci. 2024 Mar 23. doi: 10.1007/s10620-024-08379.
     PubMed     Abstract available
     
     
     
176. PEYRIN-BIROULET L, Bossuyt P, Bettenworth D, Loftus EV Jr, et al
     Comparative Efficacy of Subcutaneous and Intravenous Infliximab and Vedolizumab for Maintenance Treatment of TNF-naive Adult Patients with Inflammatory Bowel Disease: A Systematic Literature Review and Network Meta-analysis.
     Dig Dis Sci. 2024 Mar 18. doi: 10.1007/s10620-023-08252.
     PubMed     Abstract available
     
     
     
177. DEBOLT CA, Gottlieb ZS, Rao MG, Johnson S, et al
     Low-Dose Aspirin Use Does Not Increase Disease Activity in Pregnant Patients with Inflammatory Bowel Disease.
     Dig Dis Sci. 2024 Mar 16. doi: 10.1007/s10620-024-08364.
     PubMed     Abstract available
     
     
     
178. SAHYOUN LC, Fetene J, McMillan C, Protiva P, et al
     Impact of COVID-19 Treatment on Real-World Outcomes in Inflammatory Bowel Disease.
     Dig Dis Sci. 2024 Mar 11. doi: 10.1007/s10620-024-08355.
     PubMed     Abstract available
     
     
     
179. OLIVEIRA R, Martins V, de Sousa HT, Roseira J, et al
     Food-Related Quality of Life and Its Predictors in Inflammatory Bowel Disease.
     Dig Dis Sci. 2024 Mar 8. doi: 10.1007/s10620-024-08333.
     PubMed     Abstract available
     
     
     
180. KOCHAR B, Rusher A, Araka E, Glasser R, et al
     Prevalence and Appropriateness of Polypharmacy in Older Adults with Inflammatory Bowel Diseases.
     Dig Dis Sci. 2024;69:766-774.
     PubMed     Abstract available
     
     
     
181. STALLMACH A, Grunert PC
     Taking IBD Treatment in STRIDE: How Objective Disease Assessment Is Essential for the Successful Implementation of Treat-to-Target Strategies.
     Dig Dis Sci. 2024;69:657-659.
     PubMed    
     
     
     
182. VEGA P, Huguet JM, Gomez E, Rubio S, et al
     IBD-PODCAST Spain: A Close Look at Current Daily Clinical Practice in IBD Management.
     Dig Dis Sci. 2024;69:749-765.
     PubMed     Abstract available
     
     
     February 2024
183. KOLOSKI N, Shah A, Kaan I, Ben Jacob R, et al
     Healthcare Utilization Patterns: Irritable Bowel Syndrome, Inflammatory Bowel Disease, and Gastroesophageal Reflux Disease.
     Dig Dis Sci. 2024 Feb 24. doi: 10.1007/s10620-024-08297.
     PubMed     Abstract available
     
     
     
184. SU W, Liang X, Lu H, Zhang J, et al
     Concurrent Arterial and Venous Thromboses in Ulcerative Colitis: A Complex Case of Multiorgan Involvement.
     Dig Dis Sci. 2024 Feb 20. doi: 10.1007/s10620-024-08268.
     PubMed    
     
     
     
185. HUSSAIN N, Trivedi PJ
     Risk Stratification in Primary Sclerosing Cholangitis: Does Size Matter?
     Dig Dis Sci. 2024 Feb 12. doi: 10.1007/s10620-023-08262.
     PubMed    
     
     
     
186. WEIDNER J
     IBD: Who Knows Best?
     Dig Dis Sci. 2024;69:324-325.
     PubMed    
     
     
     January 2024
187. SINGH A, Bhardwaj A, Tripathi A, Ranjan MK, et al
     Burden of Anxiety, Depression and Perceived Stress in Patients with Inflammatory Bowel Disease: A Cohort Study from North India.
     Dig Dis Sci. 2024 Jan 28. doi: 10.1007/s10620-023-08242.
     PubMed     Abstract available
     
     
     
188. EIDELBERG A, Axelrad J, Chedid V, Ballou S, et al
     Sexual Health in Sexual and Gender Minority Patients with Inflammatory Bowel Disease.
     Dig Dis Sci. 2024 Jan 24. doi: 10.1007/s10620-023-08253.
     PubMed     Abstract available
     
     
     
189. MALIK A, Liu BD, Zhu L, Kaelber D, et al
     A Comprehensive Global Population-Based Analysis on the Coexistence of Eosinophilic Esophagitis and Inflammatory Bowel Disease.
     Dig Dis Sci. 2024 Jan 13. doi: 10.1007/s10620-024-08283.
     PubMed     Abstract available
     
     
     
190. PARK J, Chun J, Park SJ, Park JJ, et al
     Effectiveness and Tolerability of Methotrexate Combined with Biologics in Patients with Crohn's Disease: A Multicenter Observational Study.
     Dig Dis Sci. 2024 Jan 13. doi: 10.1007/s10620-023-08237.
     PubMed     Abstract available
     
     
     
191. ZHANG Y, Wang C, Wu L, Bai C, et al
     Epithelial CRL4(DCAF2) Is Critical for Maintaining Intestinal Homeostasis Against DSS-Induced Colitis by Regulating the Proliferation and Repair of Intestinal Epithelial Cells.
     Dig Dis Sci. 2024;69:66-80.
     PubMed     Abstract available
     
     
     
192. PALLA AH
     Regular or DCAF2: How CRL4(DCAF2) Affects IBD-Related Mucosal Injury.
     Dig Dis Sci. 2024;69:3-4.
     PubMed    
     
     
     
193. LEVITTE S
     Point-of-Care Assays for Infliximab Therapeutic Drug Monitoring in Patients with IBD: Is Quicker Better?
     Dig Dis Sci. 2024;69:5-6.
     PubMed    
     
     
     December 2023
194. MIYATANI Y, Choi D, Choi NK, Rubin DT, et al
     Dual-Targeted Therapy with Upadacitinib and Ustekinumab in Medically Complex Crohn's Disease.
     Dig Dis Sci. 2023 Dec 19. doi: 10.1007/s10620-023-08182.
     PubMed     Abstract available
     
     
     
195. VERNON-ROBERTS A, Blay L, Day AS
     Knowledge Levels About Inflammatory Bowel Disease Vary Between Healthcare Professional Groups.
     Dig Dis Sci. 2023 Dec 12. doi: 10.1007/s10620-023-08191.
     PubMed     Abstract available
     
     
     
196. COHEN NA, Choi D, Garcia N, Choi NK, et al
     Real World Clinical Effectiveness and Safety of Ozanimod in the Treatment of Ulcerative Colitis: 1-Year Follow-Up from a Tertiary Center.
     Dig Dis Sci. 2023 Dec 12. doi: 10.1007/s10620-023-08178.
     PubMed     Abstract available
     
     
     
197. MASSIRONI S, Laffusa A, Parigi TL, Danese S, et al
     Standardizing Endoscopic Reporting in Patients with IBD: JEDII to the Rescue?
     Dig Dis Sci. 2023;68:4287-4289.
     PubMed    
     
     
     
198. CONSTANT BD, Scott FI
     The PA System: Is Prior Authorization for Dose Escalation of IBD Biologic Therapy a Tolerable Alternative or a Perpetual Annoyance?
     Dig Dis Sci. 2023;68:4279-4281.
     PubMed    
     
     
     November 2023
199. GU P, Dube S, Lee Y, Yang S, et al
     Comparative Persistence of Non-tumor Necrosis Factor (TNF) vs. TNF Antagonists for Post-operative Prophylaxis in Crohn's Disease (CD).
     Dig Dis Sci. 2023 Nov 28. doi: 10.1007/s10620-023-08192.
     PubMed     Abstract available
     
     
     
200. VALDES-DELGADO T, Aguado-Paredes A, Merino-Bohorquez V, Martin-Manzanares J, et al
     Performance of a New Rapid Point-of-Care Test for Infliximab Levels in Patients with Inflammatory Bowel Disease: A Comparison to ELISA.
     Dig Dis Sci. 2023 Nov 9. doi: 10.1007/s10620-023-08139.
     PubMed     Abstract available
     
     
     October 2023
201. PIPICELLA JL, Vernon-Roberts A, Dutt S, Giles E, et al
     Co-design and Consultation Ensure Consumer Needs Are Met: Building an eHealth Platform for Children with Inflammatory Bowel Disease.
     Dig Dis Sci. 2023 Oct 28. doi: 10.1007/s10620-023-08146.
     PubMed     Abstract available
     
     
     
202. BERINSTEIN EM, Sheehan JL, Jacob J, Steiner CA, et al
     Correction to: Efficacy and Safety of Dual Targeted Therapy for Partially or Non?responsive Inflammatory Bowel Disease: A Systematic Review of the Literature.
     Dig Dis Sci. 2023 Oct 27. doi: 10.1007/s10620-023-08130.
     PubMed    
     
     
     
203. LAW CCY, Peraza J, Viera Feliciano N, Ungaro RC, et al
     Do We Need AI to Diagnose AI? Diagnosis and Management of Adrenal Insufficiency Following Steroid Therapy in a Patient with Inflammatory Bowel Disease.
     Dig Dis Sci. 2023 Oct 13. doi: 10.1007/s10620-023-08123.
     PubMed    
     
     
     
204. MCCURDY JD, Chen JH, Golden S, Kukaswadia A, et al
     Perianal Fistulas Are Associated with Persistently Higher Direct Health Care Costs in Crohn's Disease: A Population-Based Study.
     Dig Dis Sci. 2023 Oct 5. doi: 10.1007/s10620-023-08096.
     PubMed     Abstract available
     
     
     
205. PEREYRA L, Gomez EE, Gonzalez RA, Smolarczuk A, et al
     Impact of an Educational Mobile App on Inflammatory Bowel Disease Colonoscopy Report Quality.
     Dig Dis Sci. 2023 Oct 5. doi: 10.1007/s10620-023-08120.
     PubMed     Abstract available
     
     
     
206. MAAS L, Gao R, Cusumano V, Spartz E, et al
     Superior Efficacy of Infliximab Versus Adalimumab for First-Line Treatment of Crohn's Perianal Fistulae.
     Dig Dis Sci. 2023;68:3994-4000.
     PubMed     Abstract available
     
     
     September 2023
207. DUNLEAVY KA, Raffals LE, Camilleri M
     Intestinal Barrier Dysfunction in Inflammatory Bowel Disease: Underpinning Pathogenesis and Therapeutics.
     Dig Dis Sci. 2023 Sep 29. doi: 10.1007/s10620-023-08122.
     PubMed     Abstract available
     
     
     
208. DALAL RS, Baranov E, Li J, Hong X, et al
     Small Cells, Big Problems: Small Cell Carcinoma of the Rectal Cuff After Ileal-Pouch Anal Anastomosis in a Patient with Ulcerative Colitis.
     Dig Dis Sci. 2023 Sep 22. doi: 10.1007/s10620-023-08110.
     PubMed    
     
     
     
209. SHAH NB, Zuckerman AD, Hosteng KR, Fann J, et al
     Insurance Approval Delay of Biologic Therapy Dose Escalation Associated with Disease Activity in Patients with Inflammatory Bowel Disease.
     Dig Dis Sci. 2023 Sep 19. doi: 10.1007/s10620-023-08098.
     PubMed     Abstract available
     
     
     
210. COATES MD, Dalessio S, Walter V, Stuart A, et al
     Lifestyle Factors Associated with Abdominal Pain in Quiescent Inflammatory Bowel Disease.
     Dig Dis Sci. 2023 Sep 15. doi: 10.1007/s10620-023-08075.
     PubMed     Abstract available
     
     
     
211. PERRY CL, Rhudy CN
     Urban Legend: Addressing Knowledge Gaps in Inflammatory Bowel Disease Epidemiology.
     Dig Dis Sci. 2023 Sep 15. doi: 10.1007/s10620-023-08073.
     PubMed    
     
     
     
212. LIM J, Rezaie A
     Irritable Bowel Syndrome-Like Symptoms in Quiescent Inflammatory Bowel Disease: A Practical Approach to Diagnosis and Treatment of Organic Causes.
     Dig Dis Sci. 2023 Sep 11. doi: 10.1007/s10620-023-08095.
     PubMed     Abstract available
     
     
     
213. MORTON H, Coad J, Pedley KC, Irwin JR, et al
     Incidence of Inflammatory Bowel Disease in New Zealand Remains High, Findings in the Manawatu Region.
     Dig Dis Sci. 2023 Sep 2. doi: 10.1007/s10620-023-08070.
     PubMed     Abstract available
     
     
     August 2023
214. CHIOREAN M, Ha C, Hur P, Sharma PP, et al
     Experience with Tofacitinib in Patients with Ulcerative Colitis: Data from a United States Claims Database.
     Dig Dis Sci. 2023 Aug 28. doi: 10.1007/s10620-023-08063.
     PubMed     Abstract available
     
     
     
215. CUSHING K, Gudjonsson JE, Speliotes E, Higgins PDR, et al
     An Assessment of Comparative Medication Durability in Inflammatory Bowel Disease Patients With and Without Co-morbid Psoriasis, Rheumatoid Arthritis, and/or Enteropathic Arthritis.
     Dig Dis Sci. 2023 Aug 9. doi: 10.1007/s10620-023-08062.
     PubMed     Abstract available
     
     
     
216. LI T, Click B, Bachour S, Sachs M, et al
     Suboptimal Guideline Adherence and Biomarker Underutilization in Monitoring of Post-operative Crohn's Disease.
     Dig Dis Sci. 2023 Aug 7. doi: 10.1007/s10620-023-08044.
     PubMed     Abstract available
     
     
     
217. FUDMAN DI
     Monitoring Postoperative Crohn's Disease-Closing the Gap.
     Dig Dis Sci. 2023 Aug 7. doi: 10.1007/s10620-023-08051.
     PubMed    
     
     
     July 2023
218. LEE DU, Menegas S, Lee KJ, Pu A, et al
     Impact of Inflammatory Bowel Disease Subtypes on the Post-liver Transplant Outcomes of Patients with Primary Sclerosing Cholangitis.
     Dig Dis Sci. 2023 Jul 14. doi: 10.1007/s10620-023-08023.
     PubMed     Abstract available
     
     
     
219. SLEIMAN J, Patel M, Khan MZ, Falloon K, et al
     Sweet Syndrome Associated with Active Inflammatory Bowel Disease: A Case Series of a Rare Extra-intestinal Manifestation.
     Dig Dis Sci. 2023 Jul 5. doi: 10.1007/s10620-023-07983.
     PubMed     Abstract available
     
     
     
220. PATEL NB, Vinsard DG, Kattah AG, Kane SV, et al
     Decreased Risk of Preeclampsia in Women with Inflammatory Bowel Disease on Anti-Tumor Necrosis Factor Therapy.
     Dig Dis Sci. 2023 Jul 5. doi: 10.1007/s10620-023-08016.
     PubMed     Abstract available
     
     
     
221. ESCKILSEN S, Kochar B, Weaver KN, Herfarth HH, et al
     Very Early Pouchitis Is Associated with an Increased Likelihood of Chronic Inflammatory Conditions of the Pouch.
     Dig Dis Sci. 2023;68:3139-3147.
     PubMed     Abstract available
     
     
     
222. BIAN Z, Zhang Q, Qin Y, Sun X, et al
     Sodium Butyrate Inhibits Oxidative Stress and NF-kappaB/NLRP3 Activation in Dextran Sulfate Sodium Salt-Induced Colitis in Mice with Involvement of the Nrf2 Signaling Pathway and Mitophagy.
     Dig Dis Sci. 2023;68:2981-2996.
     PubMed     Abstract available
     
     
     June 2023
223. VUYYURU SK, Solitano V, Hogan M, MacDonald JK, et al
     Efficacy and Safety of IL-12/23 and IL-23 Inhibitors for Crohn's Disease: Systematic Review and Meta-Analysis.
     Dig Dis Sci. 2023 Jun 28. doi: 10.1007/s10620-023-08014.
     PubMed     Abstract available
     
     
     
224. TSE CS, Nguyen HP, Singh S, Dulai PS, et al
     Correlations Between Gastrointestinal Symptoms and Endoscopic-Histologic Disease Activity in Adults with Ulcerative Colitis.
     Dig Dis Sci. 2023 Jun 3. doi: 10.1007/s10620-023-07986.
     PubMed     Abstract available
     
     
     
225. SALWEN-DEREMER JK, Godzik CM, Jagielski CH, Siegel CA, et al
     Patients with IBD Want to Talk About Sleep and Treatments for Insomnia with Their Gastroenterologist.
     Dig Dis Sci. 2023;68:2291-2302.
     PubMed     Abstract available
     
     
     May 2023
226. KUANG R, Levinthal DJ, Ghaffari AA, Del Aguila de Rivers CR, et al
     Nightshade Vegetables: A Dietary Trigger for Worsening Inflammatory Bowel Disease and Irritable Bowel Syndrome?
     Dig Dis Sci. 2023 May 19. doi: 10.1007/s10620-023-07955.
     PubMed     Abstract available
     
     
     
227. GOGOKHIA L, Lukin DJ
     PRO Tips: First-Rate Guidance for Second-Line Therapy After Tumor Necrosis Factor-Alpha Exposure in Patients with Crohn's Disease.
     Dig Dis Sci. 2023 May 5. doi: 10.1007/s10620-023-07941.
     PubMed    
     
     
     
228. JANSEN FM, Smits LJT, Thomas PWA, de Jong DJ, et al
     Feasibility of Reduced Clinical Monitoring in Patients with Inflammatory Bowel Disease Treated with Thiopurine Therapy.
     Dig Dis Sci. 2023 May 2. doi: 10.1007/s10620-023-07950.
     PubMed     Abstract available
     
     
     
229. KIM SY, Park JH, Leite G, Pimentel M, et al
     Interleukin-10 Knockout Mice Do Not Reliably Exhibit Macroscopic Inflammation: A Natural History Endoscopic Surveillance Study.
     Dig Dis Sci. 2023;68:1858-1862.
     PubMed     Abstract available
     
     
     April 2023
230. WONG ECL, Merat S, Monaco C, Dulai PS, et al
     Comparative Efficacy of Infliximab Versus Tofacitinib for Inducing Remission in Biologic Naive Ulcerative Colitis: A Propensity Matched Study.
     Dig Dis Sci. 2023 Apr 29. doi: 10.1007/s10620-023-07956.
     PubMed     Abstract available
     
     
     
231. KAPPELMAN MD, Lewis JD, Zhang X, Lin FC, et al
     Comparing Patient-Reported Outcomes Among Anti-TNF-Experienced Patients with Crohn's Disease Initiating Vedolizumab Versus Ustekinumab.
     Dig Dis Sci. 2023 Apr 28. doi: 10.1007/s10620-023-07942.
     PubMed     Abstract available
     
     
     
232. FANTASIA S, Cortegoso Valdivia P, Gaiani F
     Ileal Acute Diverticulitis Mimicking Crohn's Disease.
     Dig Dis Sci. 2023 Apr 28. doi: 10.1007/s10620-023-07954.
     PubMed    
     
     
     
233. CHODEN T, Cohen RD
     Looking from the Past to the Future: How Janus Kinase Inhibitors Have Altered the Therapy of Ulcerative Colitis.
     Dig Dis Sci. 2023 Apr 8. doi: 10.1007/s10620-023-07933.
     PubMed    
     
     
     
234. NELSON AD, Fluxa D, Caldera F, Farraye FA, et al
     Thromboembolic Events in Hospitalized Patients with Inflammatory Bowel Disease.
     Dig Dis Sci. 2023 Apr 7. doi: 10.1007/s10620-023-07920.
     PubMed     Abstract available
     
     
     
235. DARLINGTON K, Googe P, Vedak P, Jain A, et al
     Lower Extremity Palpable Purpura in a Patient with Quiescent Inflammatory Bowel Disease.
     Dig Dis Sci. 2023 Apr 6. doi: 10.1007/s10620-023-07934.
     PubMed    
     
     
     
236. ALMASRY M, Caldera F
     Taking a JAB at How Gastroenterologists Can Increase Vaccination Rates in Patients with Inflammatory Bowel Disease.
     Dig Dis Sci. 2023 Apr 6. doi: 10.1007/s10620-023-07905.
     PubMed    
     
     
     
237. PATEL J, Noureldin M, Fakhouri D, Farraye FA, et al
     Interventions Increase Vaccination Rates in Inflammatory Bowel Disease and Rheumatoid Arthritis: A Systematic Review and Meta-Analysis.
     Dig Dis Sci. 2023 Apr 6. doi: 10.1007/s10620-023-07903.
     PubMed     Abstract available
     
     
     
238. COHEN NA, Steinberg JM, Silfen A, Traboulsi C, et al
     Endo-histologic Normalization Is Achievable with Tofacitinib and Is Associated with Improved Clinical Outcomes.
     Dig Dis Sci. 2023;68:1464-1472.
     PubMed     Abstract available
     
     
     
239. LIANG C, Tang Y, Gao X, Lei N, et al
     Depression Exacerbates Dextran Sulfate Sodium-Induced Colitis via IRF5-Mediated Macrophage Polarization.
     Dig Dis Sci. 2023;68:1269-1279.
     PubMed     Abstract available
     
     
     
240. RAJBHANDARI R, Blakemore S, Gupta N, Mannan S, et al
     Crohn's Disease Among the Poorest Billion: Burden of Crohn's Disease in Low- and Lower-Middle-Income Countries.
     Dig Dis Sci. 2023;68:1226-1236.
     PubMed     Abstract available
     
     
     March 2023
241. NOSER AE, Lancaster BD, Hommel KA, Roberts CM, et al
     Use of Behavior Change Techniques and Quality of Commercially Available Inflammatory Bowel Disease Apps.
     Dig Dis Sci. 2023 Mar 18. doi: 10.1007/s10620-023-07884.
     PubMed     Abstract available
     
     
     
242. DALAL RS, Goksel B, Hamilton MJ
     Excipient Exception: A Complication of Infliximab and Vedolizumab Infusions for Ulcerative Colitis.
     Dig Dis Sci. 2023 Mar 17. doi: 10.1007/s10620-023-07866.
     PubMed    
     
     
     
243. ERIKSSON C, Soderling J, Karlqvist S, Broms G, et al
     Ustekinumab Versus Anti-tumour Necrosis Factor Alpha Agents as Second-Line Biologics in Crohn's Disease.
     Dig Dis Sci. 2023 Mar 17. doi: 10.1007/s10620-023-07897.
     PubMed     Abstract available
     
     
     
244. UNGARO RC, Naegeli AN, Choong CK, Shan M, et al
     Early Use of Biologics Reduces Healthcare Costs in Crohn's Disease: Results from a United States Population-Based Cohort.
     Dig Dis Sci. 2023 Mar 15. doi: 10.1007/s10620-023-07906.
     PubMed     Abstract available
     
     
     
245. STRAATMIJER T, Biemans VBC, Moes DJAR, Hoentjen F, et al
     Ustekinumab Trough Concentrations Are Associated with Biochemical Outcomes in Patients with Crohn's Disease.
     Dig Dis Sci. 2023 Mar 15. doi: 10.1007/s10620-023-07822.
     PubMed     Abstract available
     
     
     
246. LEVITTE S, Peale FV, Jhun I, McBride J, et al
     Local Pentraxin-2 Deficit Is a Feature of Intestinal Fibrosis in Crohn's Disease.
     Dig Dis Sci. 2023 Mar 8. doi: 10.1007/s10620-023-07909.
     PubMed     Abstract available
     
     
     
247. AHMED T, Kayal M, Hashem D, Ungaro RC, et al
     Besting the Biologics: Vancomycin Monotherapy for Ulcerative Colitis Management in Patients with Primary Sclerosing Cholangitis.
     Dig Dis Sci. 2023 Mar 7. doi: 10.1007/s10620-023-07826.
     PubMed    
     
     
     
248. VELAYOS FS
     Rise over Runs: Elevated Creatinine and a New Diagnosis of Inflammatory Bowel Disease.
     Dig Dis Sci. 2023 Mar 7. doi: 10.1007/s10620-023-07852.
     PubMed    
     
     
     
249. CONSTANT BD, de Zoeten EF, Weinman JP, Albenberg L, et al
     Early Anti-Tumor-Necrosis-Factor Therapy for Crohn's Disease-Related Abdominal Abscesses and Phlegmon in Children.
     Dig Dis Sci. 2023;68:877-888.
     PubMed     Abstract available
     
     
     
250. AGGARWAL M, Garg R, Parthasarthy G, Nowacki AS, et al
     Crohn's Disease Is Associated with Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease.
     Dig Dis Sci. 2023;68:1006-1015.
     PubMed     Abstract available
     
     
     
251. FRIEDBERG S, Hanan I, Hyman N, Rubio G, et al
     Ileal Desmoid Tumor in Ileal Crohn's: Coincidence or Connection?
     Dig Dis Sci. 2023;68:1071-1073.
     PubMed    
     
     
     February 2023
252. MUBASHIR M, Carnell C, Haddadin I, Holubar SD, et al
     Refractory Ulcerative Colitis Requiring Preoperative Suction Thrombectomy of Submassive Bilateral Pulmonary Emboli Before Total Abdominal Colectomy.
     Dig Dis Sci. 2023 Feb 28. doi: 10.1007/s10620-023-07843.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Inflammatory Bowel Diseases is free of charge.